Sati Research Lab Cedars-Sinai Skip to content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog English English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Translation is unavailable for Internet Explorer Cedars-Sinai Home 1-800-CEDARS-1 1-800-CEDARS-1 Close Find a Doctor Locations Programs & Services Health Library Patient & Visitors Community My CS-Link RESEARCH clear Go Close Navigation Links Academics Faculty Development Community Engagement Calendar Research Research Areas Research Labs Departments & Institutes Find Clinical Trials Research Cores Research Administration Basic Science Research Clinical & Translational Research Center (CTRC) Technology & Innovations News & Breakthroughs Education Graduate Medical Education Continuing Medical Education Graduate School of Biomedical Sciences Professional Training Programs Medical Students Campus Life Office of the Dean Simulation Center Medical Library Program in the History of Medicine About Us All Education Programs Departments & Institutes Faculty Directory Sati Lab The Sati Laboratory focuses on the development of novel imaging biomarkers, magnetic resonance imaging (MRI) techniques, and artificial intelligence (AI) methods that aim to improve the clinical care offered to those impacted by neurological disorders. The relentless pace of innovation in MRI and the recent outburst of AI are the crest of a new wave of scientific tools for neurology clinics. By fully embracing these technological shifts, the Sati Laboratory is specially focused on enhancing clinicians’ ability to diagnose patients with neurological diseases earlier and more accurately, identify and anticipate the trajectory of their disease, and adapt treatment strategies to keep irreversible progression at bay. The Sati Laboratory is affiliated with the Cedars-Sinai Department of Neurology and the Biomedical Imaging Research Institute. Personal Statement I am a scientist with interdisciplinary training and I am passionate about making a difference in the lives of people with neurological disorders. My research is aimed at advancing the frontiers of neurology by harnessing scientific discoveries, technical innovations and clinical research. Pascal Sati, PhD Breakthrough Research Areas Novel imaging biomarkers for the diagnosis of multiple sclerosis Next-generation, high-resolution, magnetic susceptibility MRI for clinical integration Automated machine-learning methods for biomarker detection and disease prediction Research Grant Awards The Sati laboratory is supported by the following research grant awards: NMSS RG-2110-38526: Evaluation of Paramagnetic Rim Lesions for Early and Precise Detection of Multiple Sclerosis NIH U01NS116776: Central Vein Sign: A Diagnostic Biomarker in Multiple Sclerosis NIH R01HL14158-04S1: Microvascular Disease Burden and Cerebral Small Vessel Disease: Relations to Neurocognition Collaborations Internal Al-Louzi Lab Marwa Kaisey, MD Marcel Maya, MD Michele Tagliati, MD Frank Diaz, MD, PhD Natalie Bello, MD, PhD Bairey Merz Lab Svendsen Lab Li Lab Han Lab Gao Lab Moore Lab External Daniel Reich, MD, PhD, National Institutes of Health Daniel Ontaneda MD, PhD, Cleveland Clinic Mellen Center for Multiple Sclerosis Russell Shinohara, PhD, UPenn Perelman School of Medicine Tobias Kober, PhD, Advanced Clinical Imaging Technology at Siemens Healthineers North American Imaging in Mutiple Sclerosis Cooperative Meet Our Team Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Sati Laboratory, whose dedicated efforts lead to groundbreaking discoveries. View Our Team Job Openings The Sati Laboratory is always looking for new talents in biomedical imaging, computer sciences and neuroscience who would like to make a difference in the lives of people with neurological diseases. Contact us to inquire about any openings. Contact Us Publications Effect of GBCA Use on Detection and Diagnostic Performance of the Central Vein Sign: Evaluation Using a 3T FLAIR* Sequence in Patients With Suspected Multiple Sclerosis. Daboul L, O'Donnell CM, Cao Q, Amin M, Rodrigues P, Derbyshire J, Azevedo C, Bar-Or A, Caverzasi E, Calabresi P, et al. AJR Am J Roentgenol. 2022 Aug 17. Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial. Ontaneda D, Sati P, Raza P, Kilbane M, Gombos E, Alvarez E, Azevedo C, Calabresi P, Cohen JA, Freeman L, et al. Neuroimage Clin. 2021;32:102834. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, et al. Nat Rev Neurol. 2016 Dec;12(12):714-722. Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis. Sati P, Thomasson DM, Li N, Pham DL, Biassou NM, Reich DS, Butman JA. Mult Scler. 2014 Oct;20(11):1464-70. Contact the Sati Lab Atrium Building, 2nd Floor 8750 Beverly Blvd. Los Angeles, CA 90048 Send a Message Please ensure Javascript is enabled for purposes of website accessibility